Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
(Source: Segmental Insights Product Type Insights Why Did Injectable GLP-1 Analogues Dominate the Market in 2025
PMID: 51 PelusoJJ
H.VadivelooM.WhiteP
How We Got Here The FDA Category System and the 2023 Restriction How We Got Here The FDA Category System and the 2023 Restriction To understand what the 2026 reclassification means, you need to understand how the FDA regulates compounded medications
Another 2025 survey published in JAMA Health Forum noted that, should Medicare pay for the drugs, it could avoid spending a hypothetical $18.2 billion on obesity-related health expenditures over 10 years while dishing out $65.9 billion annually on the GLP-1s by year 10, thereby negating any savings
US$ 26.47
US$ 25.77
US$ 23.72
US$ 24.04
